About Index Trending news
Analyze
Pricing
CareDx

CareDx

Work at CareDx? Add yourself to this profile

CareDx

AlloMap is a way to non-invasively test cardiac transplant patients for their risk of acute cellular rejection, graft failure, and death.
Edit Profile
More info

Elsewhere

Companies in the same industry

Elysium Health Elysium Health RevoPT RevoPT PreparedHealth PreparedHealth Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc. Restored Hearing Restored Hearing BettrLife BettrLife Gymbox Gymbox fitpass fitpass Esperion Therapeutics Esperion Therapeutics par8o par8o

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 8
Add info
Latest funding Show all
Post-IPO debt
$25,000,000
Post-IPO equity
$22,170,000
Employees

Team size

50+
Locations
HQ
United States
Headquarters
$25,000,000 Post-IPO debt
GlobeNewswire News Room

CareDx Closes New $25 Million Debt Facility

CareDx
CareDx